Patents Assigned to Artificial Cell Technologies, Inc.
  • Patent number: 8883717
    Abstract: Multilayer films comprised of polypeptide epitopes and a toll-like receptor ligand are described. The multilayer films are capable of eliciting an immune response in a host upon administration to the host. The multilayer films can include at least one designed peptide that includes one or more polypeptide epitopes from a virus, bacteria, fungus or parasite.
    Type: Grant
    Filed: March 14, 2013
    Date of Patent: November 11, 2014
    Assignee: Artificial Cell Technologies, Inc.
    Inventors: Thomas J. Powell, James Gorham Boyd
  • Patent number: 7973129
    Abstract: Disclosed herein are polypeptide multilayer films wherein a therapeutic agent is covalently linked to a first layer polypeptide. An advantage of such attachment is that the linked therapeutic agent can be controllably released from the multilayer film into the environment of the film upon the addition of a suitable stimulus. An advantage of the disclosed films and methods is enablement of environmentally-stimulated release under specific conditions.
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: July 5, 2011
    Assignee: Artificial Cell Technologies, Inc.
    Inventor: Donald Templeton Haynie
  • Patent number: 7888316
    Abstract: Disclosed herein are polypeptide multilayer films comprising a hybrid polypeptide comprising a first polypeptide segment and a second segment, the two segments being covalently joined by one or more non-peptidic linkages. The first segment comprises a polypeptide having a magnitude of net charge per residue of greater than or equal to 0.4, and a length of greater than or equal to about 12 amino acid residues. The second segment comprises a polypeptide or another polyelectrolyte.
    Type: Grant
    Filed: April 9, 2010
    Date of Patent: February 15, 2011
    Assignee: Artificial Cell Technologies, Inc.
    Inventor: Donald T. Haynie
  • Patent number: 7807632
    Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: October 5, 2010
    Assignee: Artificial Cell Technologies, Inc.
    Inventor: Donald T. Haynie
  • Patent number: 7807633
    Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: October 5, 2010
    Assignee: Artificial Cell Technologies, Inc.
    Inventor: Donald T. Haynie
  • Patent number: 7807634
    Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: October 5, 2010
    Assignee: Artificial Cell Technologies, Inc.
    Inventor: Donald T. Haynie
  • Patent number: 7786076
    Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: August 31, 2010
    Assignee: Artificial Cell Technologies, Inc.
    Inventor: Donald T. Haynie
  • Patent number: 7781399
    Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.
    Type: Grant
    Filed: October 5, 2009
    Date of Patent: August 24, 2010
    Assignee: Artificial Cell Technologies, Inc.
    Inventor: Donald T. Haynie
  • Patent number: 7759305
    Abstract: Disclosed herein are polypeptide multilayer films wherein a therapeutic agent is covalently linked to a first layer polypeptide. An advantage of such attachment is that the linked therapeutic agent can be controllably released from the multilayer film into the environment of the film upon the addition of a suitable stimulus. An advantage of the disclosed films and methods is enablement of environmentally-stimulated release under specific conditions.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: July 20, 2010
    Assignee: Artificial Cell Technologies, Inc.
    Inventor: Donald Templeton Haynie
  • Patent number: 7723294
    Abstract: Disclosed herein are polypeptide multilayer films comprising a hybrid polypeptide comprising a first polypeptide segment and a second segment, the two segments being covalently joined by one or more non-peptidic linkages. The first segment comprises a polypeptide having a magnitude of net charge per residue of greater than or equal to 0.4, and a length of greater than or equal to about 12 amino acid residues. The second segment comprises a polypeptide or another polyelectrolyte.
    Type: Grant
    Filed: April 2, 2008
    Date of Patent: May 25, 2010
    Assignee: Artificial Cell Technologies, Inc.
    Inventor: Donald Templeton Haynie
  • Patent number: 7615530
    Abstract: Disclosed herein are immunogenic compositions comprising a multilayer film comprising two or more layers of polyelectrolytes, wherein adjacent layers comprise oppositely charged polyelectrolytes. A first layer polyelectrolyte comprises an antigenic polypeptide comprising one or more surface adsorption regions covalently linked to one or more antigenic determinant regions, wherein the antigenic polypeptide and the one or more surface adsorption regions have the same polarity. The immunogenic compositions may be employed in methods of eliciting an immune response in a vertebrate organism.
    Type: Grant
    Filed: October 25, 2006
    Date of Patent: November 10, 2009
    Assignee: Artificial Cell Technologies, Inc.
    Inventor: Donald T. Haynie
  • Publication number: 20080176080
    Abstract: Disclosed herein are polypeptide multilayer films wherein a therapeutic agent is covalently linked to a first layer polypeptide. An advantage of such attachment is that the linked therapeutic agent can be controllably released from the multilayer film into the environment of the film upon the addition of a suitable stimulus. An advantage of the disclosed films and methods is enablement of environmentally-stimulated release under specific conditions.
    Type: Application
    Filed: January 22, 2008
    Publication date: July 24, 2008
    Applicant: Artificial Cell Technologies, Inc.
    Inventor: Donald Templeton Haynie